Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®): A Multicentre, Ambispective Cohort Study

NCT04048564 is registered in ClinicalTrials.gov with Incyte BioSciences France as lead sponsor.

NCT NCT04048564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04048564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®): A Multicentre, Ambispective Cohort Study
Lead sponsor
Incyte BioSciences France
Phase
Observational
Overall status
Completed
Start date
February 23, 2018
Completion date
July 3, 2023
Enrollment
120 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia